Skip to main content

Inhibikase Therapeutics, Inc. - Common Stock (NQ:IKT)

2.005 -0.005 (-0.25%)
Streaming Delayed Price Updated: 10:27 AM EDT, Jun 11, 2025 Add to My Watchlist

Price and Volume

Detailed Quote
Volume 7,317
Open 2.050
Bid (Size) 1.990 (32)
Ask (Size) 2.020 (8)
Prev. Close 2.010
Today's Range 1.940 - 2.050
52wk Range 1.120 - 4.200
Shares Outstanding N/A
Dividend Yield N/A

Performance

YTD
-39.1%
-39.1%
1 Month
-8.4%
-8.4%
3 Month
-8.9%
-8.9%
6 Month
-37.3%
-37.3%
1 Year
+23.0%
+23.0%

Frequently Asked Questions

Is Inhibikase Therapeutics, Inc. - Common Stock publicly traded?
Yes, Inhibikase Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Inhibikase Therapeutics, Inc. - Common Stock trade on?
Inhibikase Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Inhibikase Therapeutics, Inc. - Common Stock?
The ticker symbol for Inhibikase Therapeutics, Inc. - Common Stock is IKT on the Nasdaq Stock Market
What is the current price of Inhibikase Therapeutics, Inc. - Common Stock?
The current price of Inhibikase Therapeutics, Inc. - Common Stock is 2.005
When was Inhibikase Therapeutics, Inc. - Common Stock last traded?
The last trade of Inhibikase Therapeutics, Inc. - Common Stock was at 06/11/25 10:27 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.